Class Action Alleges Dexatrim Contains Carcinogen
The lawsuit, filed Nov. 4 in the U.S. District Court for the Southern District of Indiana, contends that the product contains hexavalent chromium, a known carcinogen. The suit was filed against Chattem Inc., which makes the product and was recently purchased by Sanofi-Aventis.
The Centers for Disease Control and Prevention says workers exposed to hexavalent chromium compounds...
To view the full article, register now.